Sarmazenil
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401541This classification denotes an anxiolytic with the molecular formula C15H14ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F84AE7X24P, chemically known as ethyl 7-chloro-5,6-dihydro-5-methyl-6-oxo-4h-imidazo-(1,5-a)(1,4)benzodiazepine-3-carboxylate but generally known as sarmazenil, which bears US NIH Compound Identifier 71231. European Medicines Agency schedules Sarmazenil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10452MIG. The term SARMAZENIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). SARMAZENIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sarmazenil under HS 29339940 and SITC 51577. As of Q4 2014, SARMAZENIL remains the US FDA Preferred Term for this commodity. Sarmazenil bears US NLM identifiers UMLS ID C0532436 and NCI Concept Code C73206. SMILES: CLC1C2C(N3C(CN(C2=O)C)C(NC3)C(=O)OCC)CCC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.